| PRECLINICAL | evidence | Thymic regulation of the hypothalamic-pituitary-gonadal axis. | Thymosin beta 4 | Inflammation | 1992-04-01 |
| PRECLINICAL | evidence | Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults. | Thymosin beta 4 | — | 1992-02-01 |
| PRECLINICAL | evidence | Expression of thymosin beta-4 and related genes in developing human brain. | Thymosin beta 4 | — | 1992-01-01 |
| PRECLINICAL | evidence | [Biomolecules suppressing myelopoiesis]. | Thymosin beta 4 | Inflammation | 1992-01-01 |
| PRECLINICAL | evidence | Synthesis of a new biological response modifier thyrnosin beta(4) analogue and its restorative effect on depressed. | Thymosin beta 4 | — | 1992-01-01 |
| PRECLINICAL | evidence | Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. | TB4 | — | 1991-12-01 |
| PRECLINICAL | evidence | Is thymosin-beta4 the missing link? | Thymosin β4 | — | 1991-10-01 |
| PRECLINICAL | evidence | Cell-cycle-regulated expression of thymosin beta 4 in thymocytes. | Thymosin beta 4 | Immune function | 1991-07-15 |
| PRECLINICAL | evidence | Differential expression of thymosin genes in human tumors and in the developing human kidney. | Thymosin beta 4 | Longevity & cellular aging | 1991-07-09 |
| PRECLINICAL | evidence | Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. | Thymosin beta 4 | — | 1991-03-05 |
| PRECLINICAL | evidence | Human thymosin-beta 4/6-26 gene is part of a multigene family composed of seven members located on seven different chromosomes. | Thymosin beta 4 | — | 1991-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 Gene Expression in Leukemic Cells. | Tbeta4 | — | 1991-01-01 |
| PRECLINICAL | evidence | Thymosins: both nuclear and cytoplasmic proteins. | Thymosin beta 4 | — | 1990-09-24 |
| PRECLINICAL | evidence | Rapid induction of thymosin beta 4 in concanavalin A-stimulated thymocytes by translational control. | Thymosin beta 4 | Immune function | 1990-09-15 |
| PRECLINICAL | evidence | Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells. | Thymosin beta 4 | preclinical | 1990-09-01 |
| PRECLINICAL | evidence | Immunological effect of two synthetic peptides containing alanine or D-alanine instead of acetyl group of thymosin beta 4 after treatment of human serum. | Thymosin beta 4 | — | 1990-09-01 |
| PRECLINICAL | evidence | Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte function. | Thymosin beta 4 | Immune function · preclinical | 1990-09-01 |
| PRECLINICAL | evidence | Solution conformation of thymosin beta 4: a nuclear magnetic resonance and simulated annealing study. | Thymosin beta 4 | — | 1990-08-28 |
| PRECLINICAL | evidence | Synthesis of a thymosin beta 4-like peptide, thymosin beta Met9, and its effect on low E-rosette-forming lymphocytes of lupus nephritis patients. | Thymosin beta 4 | Immune function | 1990-08-01 |
| PRECLINICAL | evidence | Differential splicing of thymosin beta 4 mRNA. | Thymosin beta 4 | — | 1990-06-15 |
| PRECLINICAL | evidence | Biochemical characterization of thymic hormones in thymoma tissues. | Thymosin beta 4 | — | 1990-03-01 |
| PRECLINICAL | evidence | Developmental expression of mRNAs encoding thymosins beta 4 and beta 10 in rat brain and other tissues. | Thymosin beta 4 | — | 1990-01-01 |
| PRECLINICAL | evidence | Phytohemagglutin-stimulated human T cell: prothymosin alpha as an accessory signal. | Thymosin beta 4 | Immune function · preclinical | 1990-01-01 |
| PRECLINICAL | evidence | Thymosin-beta 4 gene. Preliminary characterization and expression in tissues, thymic cells, and lymphocytes. | Thymosin beta 4 | Immune function | 1989-10-15 |
| PRECLINICAL | evidence | Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages. | Thymosin beta 4 | Immune function | 1989-09-01 |
| PRECLINICAL | evidence | Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients. | Thymosin beta 4 | preclinical | 1989-09-01 |
| PRECLINICAL | evidence | Localization of immunoreactive thymosin alpha 1 in astrocytes of normal human brain. | Thymosin beta 4 | — | 1989-08-01 |
| PRECLINICAL | evidence | Possibility of HIV gp41 and thymosin beta-4 sharing the same antigenic epitope. | Thymosin beta 4 | — | 1989-05-01 |
| PRECLINICAL | evidence | Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factor. | Thymosin beta 4 | Inflammation | 1989-03-01 |
| PRECLINICAL | evidence | Isolation and structural characterization of thymosin-beta 4 from a human medullary thyroid carcinoma. | Thymosin beta 4 | — | 1988-07-01 |
| PRECLINICAL | evidence | Defective in vitro gamma interferon production and elevated serum immunoreactive thymosin beta 4 levels in patients with inflammatory bowel disease. | Thymosin beta 4 | — | 1988-04-01 |
| PRECLINICAL | evidence | Enzyme immunoassay measurement of thymosin beta 4 in human serum. | Thymosin beta 4 | preclinical | 1988-02-01 |
| PRECLINICAL | evidence | Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes. | Thymosin beta 4 | Immune function · preclinical | 1987-12-01 |
| PRECLINICAL | evidence | The role of the thymus-hypothalamus-pituitary-gonadal axis in normal immune processes and autoimmunity. | Thymosin beta 4 | Immune function | 1987-10-01 |
| PRECLINICAL | evidence | Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. | Thymosin beta 4 | — | 1987-09-01 |
| PRECLINICAL | evidence | Synthesis of calf thymosin beta 4 fragment 16-38 and its effect on the impaired blastogenic response of T-lymphocytes of a uremic patient with pneumonia. | Thymosin beta 4 | Immune function · preclinical · n = 1 | 1987-09-01 |
| PRECLINICAL | evidence | Determination of thymosin beta 4 in human blood cells and serum. | Thymosin beta 4 | preclinical | 1987-06-26 |
| PRECLINICAL | evidence | On the molecular size of thymosins. | Thymosin beta 4 | — | 1987-06-22 |
| PRECLINICAL | evidence | Immunoregulatory effects of fraction 5 thymus peptides. I. Thymosin alpha 1 enhances while thymosin beta 4 suppresses the human autologous and allogeneic mixed lymphocyte reaction. | Thymosin beta 4 | Immune function · preclinical | 1987-04-01 |
| PRECLINICAL | evidence | Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes. | Thymosin beta 4 | Immune function · preclinical | 1987-01-01 |
| PRECLINICAL | evidence | Thymosin beta 4 is a shared antigen between lymphoid cells and oligodendrocytes of normal human brain. | Thymosin beta 4 | Immune function | 1986-04-01 |
| PRECLINICAL | evidence | Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum. | Thymosin beta 4 | — | 1986-01-01 |
| PRECLINICAL | evidence | Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production. | Thymosin beta 4 | — | 1985-08-01 |
| PRECLINICAL | evidence | Biosynthesis rates and content of thymosin beta 4 in cell lines. | Thymosin beta 4 | — | 1985-07-01 |
| INDEPENDENT-REVIEW | review | It’s Thymosin Beta-4. Can that be taken daily, or should I be doing like 4-5 mg twice per week? | COMMUNITY | — | 2026-07-27 |
| INDEPENDENT-REVIEW | review | Interesting. I hope that the bpc-157 helps me recover from lifting. I've been getting kind of wiped out by it lately.
I'm also curious why the GLOW I bought has thymosin beta-4 instead of tb-500. Seems most have tb-500.
I really probably should have just bought the copper peptide by itself. I'm not really that interested in the thymosin beta-4 or the bpc-157. But I'll see what it does. There | COMMUNITY | — | 2026-06-07 |
| INDEPENDENT-REVIEW | review | This is a fair concern that comes up a lot, and it deserves an honest answer rather than the usual "don't worry about it" or "it's all fearmongering" responses you'll see in this sub.
Short version: the tumor concern is real but heavily nuanced. Here's the actual picture.
BPC-157 has shown angiogenic properties in animal studies, meaning it promotes new blood vessel formation. This is exactly | COMMUNITY | — | 2026-05-04 |
| INDEPENDENT-REVIEW | review | Oral BPC-157 and Thymosin Beta 4. Does any of it actually reach your bloodstream for injuries?
Hey all,
Just wanted to get some community perspectives on oral Thymosin Beta 4 and BPC-157. I have prescriptions through my doctor for both and they’re compounded through a local pharmacy, so everything is legitimate.
I’ve used both oral capsules before and have new scripts on the way. Thymosin Beta | COMMUNITY | — | 2026-03-06 |
| INDEPENDENT-REVIEW | review | Thymosin beta 4 and endometriosis
I am obviously not a scientist. To me, it sounds like TB4 could help the spread of endometrial tissue and maybe a peptide that people with endometriosis should avoid. Am I misinterpreting this study? | COMMUNITY | — | 2025-11-22 |
| INDEPENDENT-REVIEW | review | BPC-157 + Thymosin Beta 4 Fragment 17-23 Nasal Spray
I know injectables are golden, but I'm currently considering oral or nasal BPC-157 or something like the combo listed in title (if it's worth the much higher price). Will I get results from these? Goals: tissue healing, inflammation, etc. | COMMUNITY | — | 2025-07-31 |